Sleep, Wake and Light Therapy for Depression
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study is to determine if altering the pattern of one's sleep and having light therapy can speed up the treatment of depression. In the UK, the large majority of patients with depression in the NHS are treated in the community, and one of the major objectives of the study one is to determine if this therapy is a practical treatment in the community. We will be comparing two treatments:
- 1.Sleep Therapy and a Light Box: Participants will be given information and advice on how to get a good night's sleep. Participants will be given a light box to use in the morning for 1 week. Treatment with a light box will last 30 minutes when a person gets up. Participants may continue to have any treatment as usual (for example medication or talking therapies).
- 2.Wake therapy and a Light Box: Participants will be helped to change the pattern of sleep by depriving participants of sleep for one night. Participants will go bed at 5pm on the following day for 8 hours and get up at 1am. Participants' sleep will then be advanced by 2 hours each night for the next three nights. Participants will be also given a light box to use in the morning for 1 week. Treatment with a light box will last 30 minutes when participants get up. Participants may continue to have any treatment as usual (for example medication or talking therapies).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2018
CompletedStudy Start
First participant enrolled
January 18, 2018
CompletedFirst Posted
Study publicly available on registry
January 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 23, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 23, 2019
CompletedSeptember 26, 2019
January 1, 2019
1.7 years
January 5, 2018
September 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants recruited per month/Adherence to the protocol
To compare the rate of recruitment and adherence to the treatments in both groups
Week 1
Secondary Outcomes (13)
MINI International Neuropsychiatric Interview Version 5.0
Baseline
Hamilton Depression Rating Scale
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Clinical Global Impression and Improvement Scale (Guy, 1976)
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Quick Inventory of Depressive Symptomatology -SR Version (Triveni et al., 2004) Questionnaire
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
Brief Ruminative Response Scale (Topper et al, 2014). Questionnaire
Baseline, and at 1, 2, 4, 8 weeks and 6-month post-randomisation
- +8 more secondary outcomes
Study Arms (2)
Wake and Light Therapy
EXPERIMENTALThis consists of (a) Total Sleep Deprivation with group support on days one and two; (b) Phase Advance of Sleep over 5 days and daily Light Therapy. (c) Light Therapy is given daily
Sleep and Light Therapy
ACTIVE COMPARATORParticipants will be given information on sleep hygiene and getting a good night's sleep. They are then given Light Therapy daily for 1 week.
Interventions
Participants will be helped to change the pattern sleep by depriving participants of sleep for one night. On Day 1 participants will be supported to stay up all night and the following day at the Hospital. Participants can go to bed by 5pm at home on Day 2. Participants will need to get up by about 1am and return to the hospital to be supported to stay awake. Participants will then go to bed at 7pm on Day 3. Participants will be asked to sleep until 3am and then stay awake at home until bed at 9pm on Day 4. Participants will then get up by 5am on Day 5 and stay awake until 11pm to resume a normal sleep routine waking by 7am on Day 6. Participants will also be given a light box to use each morning. For the light box, participants will be asked to sit about one foot away from a light box. You will be free to have breakfast, read or use a computer while facing towards the light. Treatment with a light box will last 30 minutes. Participants may continue to have treatment as usual.
Participants will be given information and advice on how to get a good night's sleep. Participants will be also given a light box to use in the morning for 1 week. For the light box, participants will be asked to sit about one foot away from a light box. Participants will be free to have breakfast, read or use a computer while facing towards the light. Treatment with a light box will last 30 minutes when you get up. Participants may continue to have any treatment as usual (for example medication or talking therapies).
Eligibility Criteria
You may qualify if:
- Diagnosis of Depressive Episode (ICD10 F32) or Recurrent Depressive Disorder (F33).
- Minimum score of 8 or more on the Hamilton Depression Rating Scale (6 item) (Range 0-22) (Bech,1981).
- Age 18-65
- Able to give informed consent
You may not qualify if:
- Current diagnosis of Seasonal Affective Disorder
- Current diagnosis of anorexia nervosa or bulimia.
- Current diagnosis of an obsessive compulsive or related disorder
- Current diagnosis of post-traumatic stress disorder
- History of schizophrenia, schizoaffective disorder or bipolar disorder
- Severe cognitive impairment, dementia, intellectual disability or organic brain disorder.
- History of stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence in past 3 months.
- Borderline Personality Disorder or other personality disorder considered to be the main problem.
- Duration of depression more than 2 years.
- Significant risk of suicide that requires hospitalisation.
- Severe eye disease or cataracts or traumatic injury or visual impairment affecting both eyes.
- History of epilepsy, uncontrolled severe headaches, or stroke as this may lower seizure threshold through sleep deprivation.
- Unstable medical condition that would make wake therapy intolerable
- Untreated sleep disorder such as obstructive sleep apnoea or narcolepsy
- Use of photo-sensitizing drugs.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- Kings Health Partnerscollaborator
Study Sites (1)
South London and Maudsley NHS Foundation Trust
London, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Veale
King's College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2018
First Posted
January 23, 2018
Study Start
January 18, 2018
Primary Completion
September 23, 2019
Study Completion
September 23, 2019
Last Updated
September 26, 2019
Record last verified: 2019-01